Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Mar 22:18:35-6.
doi: 10.1016/j.rmcr.2016.03.006. eCollection 2016.

Sulfasalazine: A rare cause of acute eosinophilic pneumonia

Affiliations
Case Reports

Sulfasalazine: A rare cause of acute eosinophilic pneumonia

P Nadarajan et al. Respir Med Case Rep. .

Abstract

Sulfasalazine is a compound of 5-aminosalicylic acid (5-ASA) and sulfapyridine joined by an azo bond. It is a widely used drug in the treatment of chronic inflammatory bowel disease. Fatal toxicity of sulfasalazine arises from its effects on the bone marrow and the resulting blood dyscrasias. Pulmonary toxicity from sulfasalazine is a rather rare finding. Here, we present the case of a patient who developed acute eosinophilic pneumonia with sulfasalazine use.

Keywords: ASA, Aminosalicylic Acid; BAL, Bronchoalveolar Lavage; CRP, C-reactive protein; Drug induced lung disease; Eosinophilic pneumonia; Interstitial lung disease; MGG, May-Grunwald-Giemsa; TNF-α, Tumour necrosis factor alpha.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chest radiograph on admission.
Fig. 2
Fig. 2
Bronchoalveolar lavage cytology showing eosinophils (MGG stain).
Fig. 3
Fig. 3
Chest radiograph 2 weeks after treatment with oral corticosteroids.

References

    1. Parry S.D., Barbatzas C., Peel E.T., Barton J.R. Sulphasalazine and lung toxicity. Eur. Respir. J. 2002;19:756–764. - PubMed
    1. Davies D., MacFarlane A. Fibrosing alveolitis and treatment with sulphasalazine. Gut. 1974;15:185–188. - PMC - PubMed
    1. Baillie J. Sulfasalazine and pulmonary infiltrates. Am. J. Gastroenterol. 1984;79:77. - PubMed
    1. Scherpenisse J., van der Valk P.D., van den Bosch J.M., van Hees P.A., Nadorp J.H. J. Clin. Gastroenterol. 1988;10(2):218–220. - PubMed

Publication types